Exhibit 10.06


 


Execution Version


 


 


 





AMENDMENT #2 TO THE SECOND AMENDMENT


TO THE TECHNOLOGY, LICENSE, DEVELOPMENT, RESEARCH AND COLLABORATION
AGREEMENT


 


 


This Amendment #2 to the Second Amendment to the Technology, License,
Development, Research and Collaboration Agreement (the “Amendment #2”) is entered into to be effective as of
February 28, 2017 (the “Amendment #2 Effective Date”), by and between Amyris, Inc., a Delaware corporation having
its place of business at 5885 Hollis Street, Suite 100, Emeryville, California 94608 (“AMYRIS”) and Total Energies
Nouvelles Activités USA SAS (formerly known as Total Gas & Power USA SAS), a company existing and organized under the
French law having its head office located at 24, cours Michelet, 92800 Puteaux, France (“TOTAL”). AMYRIS and
TOTAL are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.


 


RECITALS


 


WHEREAS, on June 21, 2010, AMYRIS and TOTAL Gas & Power USA
Biotech, Inc. entered into the Technology License, Development, Research and Collaboration Agreement, as amended by the First Amendment
dated as of November 23, 2011 (the “Agreement”);


 


WHEREAS, TOTAL Gas & Power USA Biotech, Inc. assigned the Agreement
to TOTAL as set forth in that certain letter dated January 11, 2011;


 


WHEREAS, on July 30, 2012, TOTAL and AMYRIS amended certain portions
of the Agreement by entering into the Second Amendment to the Technology, License, Development, Research and Collaboration Agreement
(as subsequently amended by the Amendment #1 to the Second Amendment to the Technology, License, Development, Research and Collaboration
Agreement on April 1, 2015, collectively, the “Second Amendment”);


 


WHEREAS the Parties now desire to further amend a provision in the
Second Amendment; and


 


NOW THEREFORE, for good and valuable consideration the receipt of
which is hereby acknowledged, the Parties, intending to be legally bound, agree to the following provisions and to amend the Second
Amendment, as follows:


 


1.     
Defined Terms. All capitalized terms used, but not defined, in this Amendment #2 have the same meaning as in the
Agreement.


 


2.     
Amend Section 3.B to Extend the Term. Pursuant to Section 13.2 of the Agreement, the Parties hereby delete Section
3.B of the Second Amendment in its entirety and replace it with the following new Section 3.B:


 


“B. Term. Unless otherwise extended by the
Parties via a signed written agreement, the Biofene Development Project shall continue until the earliest to occur of (i) the Parties
terminate the Biofene Development Project by mutual written agreement signed by the Parties; or (ii) December 31, 2017.”


 


3.       No
Other Changes. Except as specifically modified herein, all other terms of the Second Amendment and the Agreement shall remain
in full force and effect.


This Amendment #2 is executed by the authorized representatives of the Parties as of
the Amendment #2 Effective Date,


 






    	 	1 of 2	 



     

    

Execution Version


 





	AMYRIS, INC.	 	TOTAL ENERGIES NOUVELLES ACTIVITES USA, SAS
	 	 	 	 	 	 
	 	/s/ John Melo	 	 	/s/ Christophe Vuillez	 
	 	 	 	 	 	 
	Name	John Melo	Name	Christophe Vuillez	 
	 	 	 	 	 	 
	Title:	President & CEO	 	Title:	Attorney in Fact	 







 


 


 


 




 


 


 


 


 


 


 


 


 


 


 


2 of 2